iStent inject Trabecular Micro-Bypass Stent System: payments to doctors
Payments that named iStent inject Trabecular Micro-Bypass Stent System as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.6M
- Providers
- 3,828
- Transactions
- 6,402
- Average per transaction
- $254
The per-transaction average — $254 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,828 providers the average total is $425, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Glaukos Corporation | $1,628,328 | 100.0% |